Thema: US8816242098
TEVA, US8816242098
tesla-6537378_1920.jpg - Foto: THN
Teva stock in focus after BXCL501 rights deal
Teva stock is in focus after the company acquired a late-stage neuroscience candidate under FDA review. BXCL501 could bring acute agitation treatment into the home.
ad-hoc-news.de, heute 15:26 Uhr
TEVA, US8816242098
Teva acquires BXCL501 rights a USD 57.50 million test for ...
BXCL501 adds an investigational at-home treatment to Teva's neuroscience pipeline. Teva Pharmaceutical Industries stock faces a fresh pipeline test.
ad-hoc-news.de, 29.10.26 15:26 Uhr
TEVA, US8816242098
Fourteen brokerages set USD 46.08 target for Teva stock
Teva posted USD 4.14 billion revenue in the second quarter of 2026. Teva stock was USD 40.33 on October 27, 2026 at 10:25 a.m. ET, up 0.95 percent on NYSE.
ad-hoc-news.de, 27.10.26 15:26 Uhr
TEVA, US8816242098
Teva reports 44-week duvakitug data for Teva stock
Duvakitug retained 58 percent remission at Week 44. Teva stock enters November 3 results after USD 4.14 billion second-quarter revenue.
ad-hoc-news.de, 27.10.26 09:07 Uhr
TEVA, US8816242098
Zacks downgrades Teva stock to Strong Sell below yearly ...
Second-quarter revenue reached USD 4.15 billion, up 4.01 percent. Teva stock was USD 39.72 on October 26, 2026, up 0.79 percent from USD 39.41.
ad-hoc-news.de, 26.10.26 15:32 Uhr
TEVA, US8816242098
Piper Sandler sets USD 44.00 target for Teva stock ahead ...
Teva posted USD 4.14 billion revenue and a USD 576.00 million loss in the second quarter. Teva stock last stood at USD 39.41 on October 23, 2026.
ad-hoc-news.de, 26.10.26 09:17 Uhr
TEVA, US8816242098
Teva stock: At 4.31 percent below its high Teva stock traded ...
Barclays kept Overweight at USD 47.00 on October 15, 2026. Teva stock was USD 40.21 on October 22, 2026 at 4:00 p.m. ET, down 1.01 percent on NYSE.
ad-hoc-news.de, 23.10.26 15:08 Uhr
TEVA, US8816242098
Teva reports Uvakitug efficacy data. November 3 results ...
Weltruza launched with three approved doses after FDA approval on October 9, 2026. For Teva stock, revenue was USD 4.14 billion before November 3 results.
ad-hoc-news.de, 23.10.26 09:59 Uhr
TEVA, US8816242098
Teva stock: Barclays raises target for Teva stock from USD ...
Weltruza revenue hit USD 77.00 million, up 43.00 percent in Q2. Teva stock was USD 39.77 on October 22, 2026, down 2.07 percent versus USD 40.62.
ad-hoc-news.de, 22.10.26 16:39 Uhr
TEVA, US8816242098
Teva reports 44-week data: What it means for Teva Pharmaceutical ...
